Medtide Inc. announced that, following the acceptance of its H Share Full Circulation application by the China Securities Regulatory Commission (CSRC) on July 27, 2025, a filing notice was issued on February 5, 2026. According to the filing notice, the conversion and listing process may proceed, and if it is not completed within 12 months from the notice’s date, an updated filing with the CSRC will be required.
Details of the conversion and listing plan have not been finalized. The H Share Full Circulation, conversion, and listing remain subject to further procedural requirements by the CSRC, The Stock Exchange of Hong Kong Limited, and other relevant domestic and overseas regulatory authorities. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.